Evaluation of serum calprotectin (MRP-8/MRP-14) levels in patients with juvenile idiopathic arthritis

Evaluation of serum calprotectin (MRP-8/MRP-14) levels in patients with juvenile idiopathic arthritis

Aim: To compare the levels of serum calprotectin (sCal) in patients with juvenile idiopathic arthritis (JIA) depending on the type of therapy to assess the disease activity comprehensively for further treatment correction. Material and methods: We determined the sCal levels in 74 JIA patients who h...

Full description

Bibliographic Details
Main Authors:	Tetiana Marushko, Yuliia Holubovska, Yeva-Emiliia Kulchytska
Format:	Article
Language:	English
Published:	Hygeia Press di Corridori Marinella 2021-03-01
Series:	Journal of Pediatric and Neonatal Individualized Medicine
Subjects:	juvenile idiopathic arthritis serum calprotectin methotrexate biological dmards
Online Access:	https://jpnim.com/index.php/jpnim/article/view/863

Similar Items

Diagnostic and Prognostic Value of Calprotectin (MRP8/MRP14) in the Blood of Patients with Different Types of Juvenile Idiopathic Arthritis
by: Ya.Ye. Boiko
Published: (2016-10-01)

Serum Calprotectin a Potential Biomarker in Juvenile Idiopathic Arthritis: A Meta-Analysis
by: Emma Altobelli, et al.
Published: (2021-10-01)

The Role of Serum Calprotectin in Defining Disease Outcomes in Non-Systemic Juvenile Idiopathic Arthritis: A Pilot Study
by: Debora Mariarita d’Angelo, et al.
Published: (2023-01-01)

Risk of infection and disease activity of patients with juvenile idiopathic arthritis treated with and without biologics
by: S. Bouayad, et al.
Published: (2022-03-01)

A new paradigm of physical development disorder in patients with juvenile idiopathic arthritis
by: T.V. Marushko, et al.
Published: (2020-04-01)

Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis, a Narrative Review
by: Claudia Iannone, et al.
Published: (2023-02-01)

Proinflammatory S100 proteins as clinical markers of juvenile idiopathic arthritis
by: Skirmantė Rusonienė, et al.
Published: (2014-12-01)

Analysis of juvenile idiopathic arthritis associated uveitis in India over the last 16 years
by: Sudharshan S, et al.
Published: (2007-01-01)

The Increased Levels of Fecal Calprotectin in Children With Active Enthesitis Related Arthritis and MRI Signs of Sacroiliitis: The Results of a Single Center Cross-Sectional Exploratory Study in Juvenile Idiopathic Arthritis Patients
by: Lovro Lamot, et al.
Published: (2021-03-01)

Spectrum of Clinical Research in Juvenile Idiopathic Arthritis: A Cross-Sectional Analysis of Registered Studies in Clinicaltrials.gov and Clinicaltrialsregister.eu
by: Ronny Lehmann, et al.
Published: (2021-12-01)

Prevalence of methotrexate intolerance in juvenile idiopathic arthritis and possible risk factors: a tertiary center experience
by: Zahide Ekici Tekin, et al.
Published: (2022-08-01)

Juvenile Idiopathic Arthritis and COVID-19 Pandemic: Good Compliance With Treatment, Reluctance to Return to School
by: Baptiste Quéré, et al.
Published: (2021-11-01)

Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
by: Sonja Falvey, et al.
Published: (2017-06-01)

Etanercept for patients with juvenile idiopathic arthritis: drug levels and influence of concomitant methotrexate: observational study
by: Tiina Levälampi, et al.
Published: (2023-03-01)

Uveitis Is a Risk Factor for Juvenile Idiopathic Arthritis' Significant Flare in Patients Treated With Biologics
by: Mikhail M. Kostik, et al.
Published: (2022-06-01)

Expanded population of low-density neutrophils in juvenile idiopathic arthritis
by: Zuzana Parackova, et al.
Published: (2023-10-01)

Measurement of serum trace elements levels in patients with juvenile idiopathic arthritis
by: Soliman A Yasser, et al.
Published: (2016-01-01)

Ultrasonographic Assessment for Tenosynovitis in Juvenile Idiopathic Arthritis with Ankle Involvement: Diagnostic and Therapeutic Significance
by: Sara Della Paolera, et al.
Published: (2022-04-01)

Cross-Cultural Adaptation and Validation of the Methotrexate Intolerance Severity Score Questionnaire in Portuguese (Brazil) for Children and Adolescents with Juvenile Idiopathic Arthritis
by: Ana Carolina Londe, et al.
Published: (2023-01-01)

Juvenile Idiopathic Arthritis-Associated Chronic Uveitis: Recent Therapeutic Approaches
by: Pierre Quartier
Published: (2021-06-01)

Methotrexate efficacy and tolerability after switching from oral to subcutaneous route of administration in juvenile idiopathic arthritis
by: Zbigniew Żuber, et al.
Published: (2016-03-01)

Metabolomic Profiling Identifies Exogenous and Microbiota-Derived Metabolites as Markers of Methotrexate Efficacy in Juvenile Idiopathic Arthritis
by: Ryan Sol Funk, et al.
Published: (2021-12-01)

Outcome of children with oligoarticular juvenile idiopathic arthritis compared to polyarthritis on methotrexate- data of the German BIKER registry
by: A. Raab, et al.
Published: (2021-03-01)

Value of Literature Review to Inform Development and Use of Biologics in Juvenile Idiopathic Arthritis
by: Klervi Golhen, et al.
Published: (2022-06-01)

Calprotectin mRNA (MRP8/MRP14) expression in neutrophils of periodontitis patients with type 2 diabetes mellitus
by: Ahmad Syaify, et al.
Published: (2009-09-01)

Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trials
by: Clara Malattia, et al.
Published: (2020-09-01)

Influence of the timing of biological treatment initiation on Juvenile Idiopathic Arthritis long-term outcomes
by: Filipa Oliveira Ramos, et al.
Published: (2023-09-01)

Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing – treatment protocol and preliminary results
by: Lea Höfel, et al.
Published: (2018-02-01)

Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis
by: Nini Kyvsgaard, et al.
Published: (2021-04-01)

The impact of single nucleotide polymorphisms in MTHFR and MTRR genes on disease activity and the presence of methotrexate treatment side effects in children with juvenile idiopathic arthritis
by: Justyna Roszkiewicz, et al.
Published: (2023-05-01)

Clinical remission and subsequent relapse in patients with juvenile idiopathic arthritis: predictive factors according to therapeutic approach
by: Mireia Castillo-Vilella, et al.
Published: (2021-08-01)

Elbow monoarthritis: an atypical onset of juvenile idiopathic arthritis Elbow monoarthritis: an atypical juvenile idiopathic arthritis onset
by: G. Simonini, et al.
Published: (2012-07-01)

Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches
by: Lina N. Zaripova, et al.
Published: (2021-08-01)

Genetic determinants for methotrexate response in juvenile idiopathic arthritis
by: Serena ePastore, et al.
Published: (2015-03-01)

Uveitis in patients with oligoarticular juvenile idiopathic arthritis and juvenile spondyloarthritis/enthesitis related arthritis: is there any difference?
by: A. Martins, et al.
Published: (2023-05-01)

Safety of the COVID-19 vaccination in children with juvenile idiopathic arthritis—A observational study from two pediatric rheumatology centres in Poland
by: Violetta Opoka-Winiarska, et al.
Published: (2023-03-01)

Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study
by: Ryoki Hara, et al.
Published: (2019-04-01)

Methotrexate inhibits BMP4 and abrogates the hypertrophic chondrocyte phenotype of synovial fibroblasts in juvenile idiopathic arthritis
by: Megan M. Simonds, et al.
Published: (2024-01-01)

Early and Accurate Prediction of Clinical Response to Methotrexate Treatment in Juvenile Idiopathic Arthritis Using Machine Learning
by: Xiaolan Mo, et al.
Published: (2019-10-01)

Vitamin D and juvenile idiopathic arthritis
by: Sarah L. Finch, et al.
Published: (2018-05-01)